当地时间 8 月 7 日,维升药业合作伙伴 Ascendis Pharma 发布了 2025 年第二季度和上半年业绩报告。第二季度,该公司营收为 1.58 亿欧元,同比大涨 339%;上半年总营收为 2.59 亿欧元,同比增长 96%。截图来源:Ascendis官网Ascendis Pharma 的收入增长主要来自于产品的收入增长。两款商业化产品上半年总计创收 2.5 亿欧元,同比大涨 155%。...
Source Link当地时间 8 月 7 日,维升药业合作伙伴 Ascendis Pharma 发布了 2025 年第二季度和上半年业绩报告。第二季度,该公司营收为 1.58 亿欧元,同比大涨 339%;上半年总营收为 2.59 亿欧元,同比增长 96%。截图来源:Ascendis官网Ascendis Pharma 的收入增长主要来自于产品的收入增长。两款商业化产品上半年总计创收 2.5 亿欧元,同比大涨 155%。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.